Radiación directamente al tumor: el innovador tratamiento realizado por primera vez en Israel
Un hombre de 77 años con glioblastoma recurrente se convirtió en el primer paciente en Israel tratado con la tecnología Alpha DaRT. En el marco del ensayo clínico en Hadassá, se insertaron fuentes diminutas de…
Valoración
A 77-year-old man with recurrent glioblastoma has become the first patient in Israel treated with Alpha DaRT technology at Hadassah. Tiny alpha radiation sources were inserted directly into the tumor, aiming to destroy it while minimizing damage to healthy brain tissue. This marks the clinical launch of a technique that could reshape treatment for aggressive brain cancers if early results justify broader trials.

